Question 1

How many shares of ARWR does JACOBS LEVY EQUITY MANAGEMENT, INC own?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC previously held 0 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN) before exiting the position in 2019-Q3.

Question 2

What is JACOBS LEVY EQUITY MANAGEMENT, INC's ARWR position worth?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC's ARWR position was last reported at $0 in 2019-Q3 before the exit.

Question 3

Is JACOBS LEVY EQUITY MANAGEMENT, INC buying or selling ARWR?

Accepted Answer

In 2019-Q3, JACOBS LEVY EQUITY MANAGEMENT, INC exited their ARWR position entirely (-100.0% change in shares).

Question 4

When did JACOBS LEVY EQUITY MANAGEMENT, INC first buy ARWR?

Accepted Answer

Based on available 13F filings, JACOBS LEVY EQUITY MANAGEMENT, INC first reported a position in ARWR in 2018-Q4. They have held the position across 4 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2019-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$26.96	0
2019-Q2	Unchanged	33,500	0.0%	$888,000	0.0%	$26.50	0
2019-Q1	Unchanged	33,500	0.0%	$615,000	0.0%	$18.35	0
2018-Q4	New	33,500	-	$416,000	0.0%	$11.94	33

ARWR4 quarters

ARWR
4 quarters